144 related articles for article (PubMed ID: 16760408)
21. Inhibition of human immunodeficiency virus type 1 in human T cells by a potent Rev response element decoy consisting of the 13-nucleotide minimal Rev-binding domain.
Lee SW; Gallardo HF; Gilboa E; Smith C
J Virol; 1994 Dec; 68(12):8254-64. PubMed ID: 7966618
[TBL] [Abstract][Full Text] [Related]
22. Acetoxybenzhydrols as highly active and stable analogues of 1'S-1'-acetoxychavicol, a potent antiallergic principal from Alpinia galanga.
Yasuhara T; Manse Y; Morimoto T; Qilong W; Matsuda H; Yoshikawa M; Muraoka O
Bioorg Med Chem Lett; 2009 Jun; 19(11):2944-6. PubMed ID: 19414259
[TBL] [Abstract][Full Text] [Related]
23. Decoy approach using RNA-DNA chimera oligonucleotides to inhibit the regulatory function of human immunodeficiency virus type 1 Rev protein.
Nakaya T; Iwai S; Fujinaga K; Sato Y; Otsuka E; Ikuta K
Antimicrob Agents Chemother; 1997 Feb; 41(2):319-25. PubMed ID: 9021186
[TBL] [Abstract][Full Text] [Related]
24. [HIV-1 Rev and related inhibitors].
Cao Y; Liu XY
Yao Xue Xue Bao; 2007 Apr; 42(4):347-51. PubMed ID: 17633198
[TBL] [Abstract][Full Text] [Related]
25. The bis-azo compound FP-21399 inhibits HIV-1 replication by preventing viral entry.
Zhang JL; Choe H; Dezube BJ; Farzan M; Sharma PL; Zhou XC; Chen LB; Ono M; Gillies S; Wu Y; Sodroski JG; Crumpacker CS
Virology; 1998 May; 244(2):530-41. PubMed ID: 9601521
[TBL] [Abstract][Full Text] [Related]
26. Antiallergic principles from Alpinia galanga: structural requirements of phenylpropanoids for inhibition of degranulation and release of TNF-alpha and IL-4 in RBL-2H3 cells.
Matsuda H; Morikawa T; Managi H; Yoshikawa M
Bioorg Med Chem Lett; 2003 Oct; 13(19):3197-202. PubMed ID: 12951092
[TBL] [Abstract][Full Text] [Related]
27. 1'S-1'-acetoxyeugenol acetate: a new chemotherapeutic natural compound against MCF-7 human breast cancer cells.
Hasima N; Aun LI; Azmi MN; Aziz AN; Thirthagiri E; Ibrahim H; Awang K
Phytomedicine; 2010 Oct; 17(12):935-9. PubMed ID: 20729047
[TBL] [Abstract][Full Text] [Related]
28. Analysis of trans-dominant mutants of the HIV type 1 Rev protein for their ability to inhibit Rev function, HIV type 1 replication, and their use as anti-HIV gene therapeutics.
Ragheb JA; Bressler P; Daucher M; Chiang L; Chuah MK; VandenDriessche T; Morgan RA
AIDS Res Hum Retroviruses; 1995 Nov; 11(11):1343-53. PubMed ID: 8573391
[TBL] [Abstract][Full Text] [Related]
29. Identification of benzenesulfonamide quinoline derivatives as potent HIV-1 replication inhibitors targeting Rev protein.
Zhong F; Geng G; Chen B; Pan T; Li Q; Zhang H; Bai C
Org Biomol Chem; 2015 Feb; 13(6):1792-9. PubMed ID: 25503645
[TBL] [Abstract][Full Text] [Related]
30. Interaction between HIV-1 Rev and integrase proteins: a basis for the development of anti-HIV peptides.
Rosenbluh J; Hayouka Z; Loya S; Levin A; Armon-Omer A; Britan E; Hizi A; Kotler M; Friedler A; Loyter A
J Biol Chem; 2007 May; 282(21):15743-53. PubMed ID: 17403681
[TBL] [Abstract][Full Text] [Related]
31. A chimeric human immunodeficiency virus type 1 (HIV-1) minimal Rev response element-ribozyme molecule exhibits dual antiviral function and inhibits cell-cell transmission of HIV-1.
Yamada O; Kraus G; Luznik L; Yu M; Wong-Staal F
J Virol; 1996 Mar; 70(3):1596-601. PubMed ID: 8627679
[TBL] [Abstract][Full Text] [Related]
32. 1'S-1'-Acetoxychavicol acetate as a new type inhibitor of interferon-beta production in lipopolysaccharide-activated mouse peritoneal macrophages.
Ando S; Matsuda H; Morikawa T; Yoshikawa M
Bioorg Med Chem; 2005 May; 13(9):3289-94. PubMed ID: 15809164
[TBL] [Abstract][Full Text] [Related]
33. Nuclear Factor 90, a cellular dsRNA binding protein inhibits the HIV Rev-export function.
Urcuqui-Inchima S; Castaño ME; Hernandez-Verdun D; St-Laurent G; Kumar A
Retrovirology; 2006 Nov; 3():83. PubMed ID: 17125513
[TBL] [Abstract][Full Text] [Related]
34. Modulation of the Rev-RRE interaction by aromatic heterocyclic compounds.
Zapp ML; Young DW; Kumar A; Singh R; Boykin DW; Wilson WD; Green MR
Bioorg Med Chem; 1997 Jun; 5(6):1149-55. PubMed ID: 9222509
[TBL] [Abstract][Full Text] [Related]
35. Transduction of human CD34+ hematopoietic progenitor cells by a retroviral vector expressing an RRE decoy inhibits human immunodeficiency virus type 1 replication in myelomonocytic cells produced in long-term culture.
Bahner I; Kearns K; Hao QL; Smogorzewska EM; Kohn DB
J Virol; 1996 Jul; 70(7):4352-60. PubMed ID: 8676458
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of acute-, latent-, and chronic-phase human immunodeficiency virus type 1 (HIV-1) replication by a bistriazoloacridone analog that selectively inhibits HIV-1 transcription.
Turpin JA; Buckheit RW; Derse D; Hollingshead M; Williamson K; Palamone C; Osterling MC; Hill SA; Graham L; Schaeffer CA; Bu M; Huang M; Cholody WM; Michejda CJ; Rice WG
Antimicrob Agents Chemother; 1998 Mar; 42(3):487-94. PubMed ID: 9517921
[TBL] [Abstract][Full Text] [Related]
37. Intracellular immunization against HIV-1 infection of human T lymphocytes: utility of anti-rev single-chain variable fragments.
Duan L; Zhu M; Bagasra O; Pomerantz RJ
Hum Gene Ther; 1995 Dec; 6(12):1561-73. PubMed ID: 8664381
[TBL] [Abstract][Full Text] [Related]
38. Croton megalobotrys Müll Arg. and Vitex doniana (Sweet): Traditional medicinal plants in a three-step treatment regimen that inhibit in vitro replication of HIV-1.
Tietjen I; Gatonye T; Ngwenya BN; Namushe A; Simonambanga S; Muzila M; Mwimanzi P; Xiao J; Fedida D; Brumme ZL; Brockman MA; Andrae-Marobela K
J Ethnopharmacol; 2016 Sep; 191():331-340. PubMed ID: 27350006
[TBL] [Abstract][Full Text] [Related]
39. The carboxy-terminal region of the human immunodeficiency virus type 1 protein Rev has multiple roles in mediating CRM1-related Rev functions.
Hakata Y; Yamada M; Mabuchi N; Shida H
J Virol; 2002 Aug; 76(16):8079-89. PubMed ID: 12134013
[TBL] [Abstract][Full Text] [Related]
40. Binding of intracellular anti-Rev single chain variable fragments to different epitopes of human immunodeficiency virus type 1 rev: variations in viral inhibition.
Wu Y; Duan L; Zhu M; Hu B; Kubota S; Bagasra O; Pomerantz RJ
J Virol; 1996 May; 70(5):3290-7. PubMed ID: 8627813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
